The importance of adjuvant formulation in the development of a TB vaccine

Por Baldwin, Susan L., Bertholet, Sylvie, Reese, Valerie A., Ching, Lance K., Reed, Steven G., Coler, Rhea N.
Publicado em 2012

The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative

Por Baldwin, Susan L., Reese, Valerie, Granger, Brian, Orr, Mark T., Ireton, Gregory C., Coler, Rhea N., Reed, Steven G.
Publicado em 2014

Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate

Por Baldwin, Susan L., Reese, Valerie A., Huang, Po-wei D., Beebe, Elyse A., Podell, Brendan K., Reed, Steven G., Coler, Rhea N.
Publicado no Clin Vaccine Immunol (2016)

Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis()

Por Orr, Mark T., Ireton, Gregory C., Beebe, Elyse A., Huang, Po-Wei D., Reese, Valerie A., Argilla, David, Coler, Rhea N., Reed, Steven G.
Publicado em 2014

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4(+) T-Cell Responses for Vaccine Control of Tuberculosis

Por Orr, Mark T., Windish, Hillarie Plessner, Beebe, Elyse A., Argilla, David, Huang, Po-Wei D., Reese, Valerie A., Reed, Steven G., Coler, Rhea N.
Publicado no J Infect Dis (2015)

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

Por Larsen, Sasha E., Baldwin, Susan L., Orr, Mark T., Reese, Valerie A., Pecor, Tiffany, Granger, Brian, Dubois Cauwelaert, Natasha, Podell, Brendan K., Coler, Rhea N.
Publicado no Vaccines (Basel) (2018)

Examining the Effectiveness of Provider Incentives to Increase CRC Screening Uptake in Neighborhood Healthcare: A California Federally Qualified Health Center

Por Barajas, Melissa, Tangka, Florence K. L., Schultz, James, Tantod, Kulin, Kempster, Ying Marilyn, Omelu, Ndukaku, Hoover, Sonja, Thomas, Melonie, Richmond-Reese, Valerie, Subramanian, Sujha
Publicado no Health Promot Pract (2020)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model

Por Baldwin, Susan L., Reese, Valerie A., Larsen, Sasha E., Beebe, Elyse, Guderian, Jeff, Orr, Mark T., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Publicado no PLoS One (2021)

Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment

Por Coler, Rhea N., Bertholet, Sylvie, Pine, Samuel O., Orr, Mark T., Reese, Valerie, Windish, Hillarie Plessner, Davis, Charles, Kahn, Maria, Baldwin, Susan L., Reed, Steven G.
Publicado em 2013

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic T(H)1 to tissue-resident T(H)17 responses without impacting the protective efficacy(§)

Por Orr, Mark T., Beebe, Elyse A., Hudson, Thomas, Argilla, David, Huang, Po-Wei D., Reese, Valerie A., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Publicado no Vaccine (2015)

Economic Assessment of Patient Navigation to Colonoscopy-Based Colorectal Cancer Screening in the Real-World Setting at the University of Chicago Medical Center

Por Kim, Karen E., Randal, Fornessa, Johnson, Matt, Quinn, Michael, Maene, Chieko, Hoover, Sonja, Richmond-Reese, Valerie, Tangka, Florence K. L., Joseph, Djenaba A., Subramanian, Sujha
Publicado no Cancer (2018)

Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29

Por Carrigy, Nicholas B., Larsen, Sasha E., Reese, Valerie, Pecor, Tiffany, Harrison, Melissa, Kuehl, Philip J., Hatfull, Graham F., Sauvageau, Dominic, Baldwin, Susan L., Finlay, Warren H., Coler, Rhea N., Vehring, Reinhard
Publicado no Antimicrob Agents Chemother (2019)